Feb 23, 20231 min readOrally delivered single-domain antibodies against gastrointestinal pathogensPetersson et al (2023) Trends in Biotech 41(7):P875-886This publication describes how nanobodies can be orally administered and discusses the benefits and strengths of this platform. Read full article here.
Petersson et al (2023) Trends in Biotech 41(7):P875-886This publication describes how nanobodies can be orally administered and discusses the benefits and strengths of this platform. Read full article here.
Commentaires